article thumbnail

RCT of PC in ED: Corita Grudzen, Fernanda Bellolio, & Tammie Quest

GeriPal

You know, most, most ERs admit, you know, far fewer than 50% of their patients. They go to observation and go home or just get discharged straight from the ER? Eric 26:01 Curtis’s, he had a 2014 JAMA article on simulation. Would it have changed potentially utilization rates like hospice utilization?

article thumbnail

Sweet! A Metabolic Disorders focused podcast episode

PEMBlog

She did her MD/PhD at Columbia University, where she investigated the diagnostic utility of exome sequencing for kidney disease. So, again, to reinforce, since IEMs have very specific non specific presentations, the goal in the ER is not to specifically diagnose the IEM. You can contact her via email at egroopman@childrensnational.org.

article thumbnail

Ding Dong is the Skinny Label (Effectively) Dead?

FDA Law Blog

Briefly (more detail is available here ), GSK sued Teva back in 2014 alleging that Teva induced infringement of a method-of-use patent when Teva marketed a skinny-labeled generic version of GSK’s Coreg (carvedilol) as AB-rated. Instead, it was GSK who erred in omitting the post-MI language from the use code.

IT 52